These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15670032

  • 1. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S, Ekman GJ, Hedner U.
    J Thromb Haemost; 2005 Feb; 3(2):272-9. PubMed ID: 15670032
    [Abstract] [Full Text] [Related]

  • 2. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
    He S, Blombäck M, Jacobsson Ekman G, Hedner U.
    J Thromb Haemost; 2003 Jun; 1(6):1215-9. PubMed ID: 12871322
    [Abstract] [Full Text] [Related]

  • 3. General haemostatic agents--fact or fiction?
    Hedner U.
    Pathophysiol Haemost Thromb; 2002 Jun; 32 Suppl 1():33-6. PubMed ID: 12214145
    [Abstract] [Full Text] [Related]

  • 4. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action, development and clinical experience of recombinant FVIIa.
    Hedner U.
    J Biotechnol; 2006 Aug 05; 124(4):747-57. PubMed ID: 16697480
    [Abstract] [Full Text] [Related]

  • 6. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U.
    J Thromb Haemost; 2006 Jan 05; 4(1):192-200. PubMed ID: 16409469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
    Gray LD, Hussey MA, Larson BM, Machlus KR, Campbell RA, Koch G, Ezban M, Hedner U, Wolberg AS.
    Thromb Res; 2011 Dec 05; 128(6):570-6. PubMed ID: 21561645
    [Abstract] [Full Text] [Related]

  • 10. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.
    Lisman T, Adelmeijer J, Heijnen HF, de Groot PG.
    Blood; 2004 Mar 01; 103(5):1720-7. PubMed ID: 14592825
    [Abstract] [Full Text] [Related]

  • 11. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
    Lisman T, Adelmeijer J, Cauwenberghs S, Van Pampus EC, Heemskerk JW, De Groot PG.
    J Thromb Haemost; 2005 Apr 01; 3(4):742-51. PubMed ID: 15842358
    [Abstract] [Full Text] [Related]

  • 12. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U.
    Curr Opin Hematol; 2007 May 01; 14(3):225-9. PubMed ID: 17414211
    [Abstract] [Full Text] [Related]

  • 13. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
    Antovic JP, Antovic A.
    Thromb Haemost; 2003 Oct 01; 90(4):620-7. PubMed ID: 14515182
    [Abstract] [Full Text] [Related]

  • 14. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
    Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, De Groot PG.
    Blood; 2003 Mar 01; 101(5):1864-70. PubMed ID: 12411291
    [Abstract] [Full Text] [Related]

  • 15. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
    Galán AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G.
    Transfusion; 2003 Jul 01; 43(7):885-92. PubMed ID: 12823748
    [Abstract] [Full Text] [Related]

  • 16. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT, Chakroun T, Depasse F, Arzoglou P, Samama MM, Elalamy I.
    Thromb Haemost; 2004 May 01; 91(5):977-85. PubMed ID: 15116259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
    Dargaud Y, Bordet JC, Trzeciak MC, Vinciguerra C, Negrier C.
    Haematologica; 2006 Jun 01; 91(6 Suppl):ECR20. PubMed ID: 16785139
    [Abstract] [Full Text] [Related]

  • 19. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
    Aljamali MN, Kjalke M, Hedner U, Ezban M, Tranholm M.
    Haemophilia; 2009 Nov 01; 15(6):1318-26. PubMed ID: 19659796
    [Abstract] [Full Text] [Related]

  • 20. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F, Taketomi T, Sheppard CA, Kempton CL, Levy JH, Tanaka KA.
    Anesth Analg; 2008 Mar 01; 106(3):719-24, table of contents. PubMed ID: 18292408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.